FDA approves $3.5 million treatment for hemophilia, now the most expensive drug in the world
The US Food and Drug Administration on Tuesday approved Hemgenix, a new drug to treat hemophilia. Manufacturer CSL Behring set the price at $3.5 million per treatment, making it the most expensive drug in the world. Hemgenix is a gene therapy to treat adults with hemophilia B, a genetic bleeding disorder in which [...]